SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-15-008807
Filing Date
2015-01-13
Accepted
2015-01-13 08:08:31
Documents
4
Group Members
BIGARADE CORPOTSUKA AMERICA, INC.OTSUKA PHARMACEUTICAL CO., LTD.

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d850708dsctota.htm SC TO-T/A 36876
2 EX-99.A.5.G d850708dex99a5g.htm EX-99.A.5.G 31786
3 GRAPHIC g850708g48m42.jpg GRAPHIC 9456
4 GRAPHIC g850708g97w29.jpg GRAPHIC 9312
  Complete submission text file 0001193125-15-008807.txt   96704
Mailing Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656
Business Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS, INC. (Subject) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC TO-T/A | Act: 34 | File No.: 005-41430 | Film No.: 15523398
SIC: 2834 Pharmaceutical Preparations

Mailing Address SHINAGAWA GRAND CENTRAL TOWER 2-16-4 KONAN, MINATO-KU TOKYO M0 108-8242
Business Address SHINAGAWA GRAND CENTRAL TOWER 2-16-4 KONAN, MINATO-KU TOKYO M0 108-8242 011-81-3-6717-1400
Otsuka Holdings Co., Ltd. (Filed by) CIK: 0001586698 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 0314
Type: SC TO-T/A